Premier Path Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$920K Sell
11,763
-4,292
-27% -$346K 0.11% 183
2026
Q1
$1.39M Sell
16,055
-549
-3% -$52.6K 0.18% 127
2025
Q4
$1.6M Sell
16,604
-1,132
-6% -$110K 0.21% 102
2025
Q3
$1.69M Sell
17,736
-15
-0.1% -$1.38K 0.22% 99
2025
Q2
$1.55M Buy
17,751
+192
+1% +$16.3K 0.22% 109
2025
Q1
$1.58M Buy
17,559
+47
+0.3% +$4.21K 0.25% 97
2024
Q4
$1.4M Sell
17,512
-12
-0.1% -$1.04K 0.21% 104
2024
Q3
$1.58M Buy
17,524
+389
+2% +$32.7K 0.25% 96
2024
Q2
$1.35M Buy
17,135
+579
+3% +$47.5K 0.23% 105
2024
Q1
$1.43M Buy
16,556
+2,817
+21% +$240K 0.27% 93
2023
Q4
$1.14M Buy
+13,739
New +$1.05M 0.25% 99

Other funds holding MDT

Premier Path Wealth Partners's MDT Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its Medtronic (MDT) stake by 27% in Q2 2026, selling an estimated $346K and leaving 11,763 shares worth $920K. The position accounts for 0.11% of the portfolio, ranked #183.

Premier Path Wealth Partners first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.69M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Premier Path Wealth Partners held 11,763 shares of Medtronic worth $920K as of Q2 2026.
  • Premier Path Wealth Partners sold 4,292 Medtronic shares in Q2 2026, an estimated $346K.
  • Medtronic made up 0.11% of Premier Path Wealth Partners's portfolio in Q2 2026, its #183 holding.
  • Premier Path Wealth Partners first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Premier Path Wealth Partners's Medtronic position peaked at $1.69M in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.